To compare the results of neurosonography (NSG) with subsequent neurodevelopmental testing in extremely low birth weight (ELBW; r1000 g) neonates.
INTRODUCTION
Extremely low birth weight (ELBW; r1000 g) neonates are the group of preterm infants at highest risk for subsequent abnormalities in cognitive and motor development. Several investigators have examined the value of neurosonography (NSG) in predicting neurodevelopmental outcome in preterm neonates; however, these studies generally have included infants with birth weight r1500 or r1250 g. [1] [2] [3] [4] [5] [6] These authors report that despite normal NSG, preterm neonates may be at increased risk for cognitive and/or motor deficits; conversely, normal neurologic outcome has been noted in infants with abnormal ultrasound scans. 3, 7, 8 Neurodevelopmental outcome is an important topic for discussion with parents of ELBW neonates, and this subject receives special emphasis as hospital discharge approaches. In our institution, a neurosonogram is obtained just prior to discharge (NSG-DC) in the majority of ELBW neonates. However, since the ability of NSG to detect diffuse or subtle brain injury has not been completely elucidated, 3, [9] [10] [11] it is unclear to what extent a normal study should influence the discussion with an infant's parents in a positive direction, and conversely, whether an abnormal study should suggest less than optimal outcome. 12, 13 To our knowledge, no studies to date have related NSG-DC and outcome at 18 to 22 months corrected age exclusively in this high-risk population.
The purpose of this study was to provide additional information to improve communication between clinicians and parents of ELBW neonates by examining the relationship between NSG-DC and cognitive and psychomotor testing at 18 to 22 months corrected age. We were particularly interested in the outcome of those infants in whom NSG-DC was normal. In addition, we assessed neurodevelopmental outcome when all cranial ultrasound studies during hospitalization (NSG-All) were considered. We hypothesized that NSG-DC would be a poor predictor of subsequent outcome.
METHODS
All ELBW neonates born at Parkland Memorial Hospital between May 1, 1994 and December 31, 1997 with birth weights r1000 g who survived until discharge were eligible, and this population was assessed using a prospectively collected and previously validated database.
14-16 NSG-DC results were available for 164 of the 174 (94%) infants. Bayley Scores of Infant Development (BSID II; mental scale ¼ MDI, psychomotor scale ¼ PDI) at 18 to 22 months corrected age were available in 95% (92/97) of those with normal NSG-DC and 99% (66/67) with abnormal NSG-DC (Figure 1 ). In 141 of the 158 infants (89%), both MDI and PDI were performed; because of a lack of cooperation necessary to obtain valid results, testing was limited to only MDI in nine infants (6%) and only PDI in eight infants (5%).
NSG was performed at the bedside using an Acuson 128 XP/10 (Mountain View, CA), and the sonographic studies were analyzed by the Pediatric Radiology staff at Children's Medical Center of Dallas. The initial head ultrasound study in ELBW neonates was obtained in most patients on the second to third day of life. Subsequent NSG was performed as clinically indicated, and a final study was obtained close to the time of hospital discharge. Intracranial hemorrhage was graded according to Papile et al., 17 with the exception that the Grade IV classification was not used, and intraparenchymal hemorrhages were described by their location. The diagnosis of periventricular leukomalacia (PVL) was not made until cystic changes in the periventricular white matter were observed, and increased periventricular echogenicity was considered a separate diagnosis. Cysts noted on an earlier study were not always apparent at discharge; however, in some instances, dilatation of the lateral ventricles or extra-axial fluid was seen. 18 The diagnosis of resolving IVH was made when serial studies indicated that the intraventricular clot was retracting.
BSID II examinations were performed in the Low Birth Weight Clinic at Children's Medical Center of Dallas by certified examiners who were masked to the NSG results. For the BSID II, the mean is assigned a value of 100; a score of 85 represents 1 standard deviation (SD) below the mean, and 70 represents 2SD below the mean. Scores between 70 and 84 are associated with mildmoderate neurodevelopmental delay, and scores less than 70 are associated with severe delay.
Continuous and categorical data were compared by t-test and w 2 analysis, respectively, and median values were compared by Mann-Whitney U-test. All tests of statistical significance were twosided, with significance being defined as a<0.05. The Bonferroni correction was used when multiple comparisons were made. The ability of NSG-DC or NSG-All to predict neurodevelopmental outcome was assessed, and sensitivity, specificity, and positive and negative predictive values were calculated according to standard formulae. 19 In addition, a multinomial logistic regression analysis was used to predict the effect of NSG-DC on subsequent BSID-II scores. In this analysis, the following variables that differed between the NSG-DC normal and NSG-DC abnormal groups were controlled: (a) number of days requiring supplemental oxygen, (b) postnatal dexamethasone for chronic lung disease, and (c) length of stay.
This study was approved by the Institutional Review Board at the University of Texas Southwestern Medical Center at Dallas. Informed consent was not required.
RESULTS
A description of the study population is shown in Table 1 . When the study patients were categorized according to normal vs abnormal NSG-DC, significant differences were observed for number of days requiring supplemental oxygen, postnatal dexamethasone therapy for chronic lung disease, and length of stay, all of which were greater in the abnormal NSG-DC group. The percentage of mothers completing 12th grade or higher was not different between the normal and abnormal NSG-DC groups.
Sonographic diagnoses at NSG-DC in study neonates are shown in Table 2 . Approximately 50% of those with any individual diagnosis (some infants had more than one abnormality diagnosed at discharge) had an MDI or PDI score of X85. The resolving IVH category included six of the nine neonates who had been previously diagnosed with Grade 3 IVH. Cystic PVL was associated significantly with PDI <70 (P<0.05) but not with MDI <70; however, this diagnosis was made in only 18 infants (11%). LeFlore et al.
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The distribution of BSID scores in relation to NSG-DC and NSGAll is shown in Table 3 . When only the NSG-DC was considered, 44% (14/32) of the neonates with MDI <70 and 29% (7/24) with PDI <70 had a normal study. The NSG-DC was normal in 59% (36/61) of the infants with MDI 70 to 84 and 56% (31/55) of the infants with PDI 70 to 84. When all NSG studies were considered, the percentages of infants with all normal studies and MDI or PDI <70 were lower (19 and 8%, respectively) as were the percentages for MDI or PDI 70 to 84 (31 and 31%, respectively). However, when all NSG studies were normal, outcome was still less than optimal (scores less than 85) in 54 and 41% for the MDI and PDI, respectively. Conversely, approximately 30 to 40% of those with an abnormality noted on neurosonogram at discharge, or at any time during hospitalization, had MDI and/or PDI scores Z85.
Abnormal NSG-DC had low sensitivity and specificity for all BSID II cutoff values examined (Table 4) . Negative predictive value (NPV) was high for both MDI <70 (0.84) and PDI <70 (0.92). However, NPV was lower for MDI <85 (0.44) and PDI <85 (0.57). At each MDI or PDI cutoff level, the positive likelihood ratio for abnormal NSG-DC was r2.
For each BSID II cutoff value, sensitivity was higher and specificity was lower when any NSG abnormality during the hospitalization was considered (Table 5 ) as compared with NSG-DC values ( Table 4) . As was the case when only the NSG-DC study was considered, NPV when all neurosonograms were normal was high for MDI <70 (0.87) and PDI <70 (0.96). As observed in the NSG-DC analysis, NPV was lower for MDI <85 (0.46) and PDI <85 (0.59). Positive likelihood ratios were r1.4 for each BSID II cutoff value examined.
For each BSID II cutoff value, the association between abnormal NSG-DC or NSG-All and low BSID II results was stronger for the PDI exam than for the MDI exam (Table 6 ). Abnormal NSG was associated significantly with PDI <70 both for NSG-DC (odds ratio 4.5) and for NSG-All (odds ratio 6.0), and with PDI <85 for NSG-DC (odds ratio 2.7). However, when number of days requiring supplemental oxygen, postnatal dexamethasone, and length of stay were controlled in a multinomial logistic regression, abnormal NSG-DC was predictive of MDI <70 and <85 (both p<0.001) and PDI <70 and <85 (both p<0.001). There was no significant relationship between maternal education and either MDI ( p ¼ 0.26) or PDI ( p ¼ 0.97). n(%) where n=number of infants with the designated diagnosis; some infants had more than one sonographic abnormality. IVH, intraventricular hemorrhage; mPV echos, increased periventricular echogenicity; PVL, periventricular leukomalacia. other includes choroid cyst, basal ganglia calcification, extra-axial fluid, white matter atrophy.
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DISCUSSION
This study examined the relationship between NSG at hospital discharge, as well as all cranial ultrasound studies obtained during hospitalization, and outcome in a large cohort of ELBW neonates. NSG-DC was chosen as the primary ultrasound for the analysis since, as noted by Ment et al, 20 36 to 40 weeks postmenstral age is the optimal time to detect lesions such as PVL and ventriculomegaly, which are considered to be predictive of longterm neurodevelopmental outcome. In addition, we used a test that is commonly used in this population at approximately 2 years of age, the BSID II, a measure of outcome that has been shown to correlate with school performance and subsequent development of cerebral palsy. 21 The primary goal of this study was to provide information that might enhance the ability of the clinician to discuss the results of NSG and anticipated outcome with the parents of high-risk neonates. Our results demonstrate the limitations of NSG in predicting subsequent neurodevelopmental outcome in ELBW neonates.
Maalouf et al. 11 compared cranial ultrasound and magnetic resonance imaging (MRI) findings in preterm infants with birth weights ranging from 530 to 1710 g. Cranial ultrasound predicted accurately the presence of germinal layer hemorrhage, IVH, and hemorrhagic parenchymal infarction on MRI. However, normal white matter echogenicity on ultrasound was found to be a poor predictor of normal white matter signal intensity on MRI. Other investigators have reported that as much as 70% of periventricular white matter injury is not detected consistently in vivo by ultrasonography. [22] [23] [24] [25] [26] Therefore, the observed inability of NSG to predict accurately subsequent outcome in the present study may be explained by a lack of sensitivity of NSG to detect subtle central nervous system injury.
The observations of Armstrong et al. 27 may provide an additional explanation. These investigators measured subarachnoid space width by initial and follow-up ultrasound scans and concurrently determined head circumference in preterm neonates <37 weeks gestation (mean, 30 weeks). These serial measurements allowed the investigators to compare infants with similar postconceptional age, for example, a 29-week infant several days postnatal and a 25-week infant 4 weeks postnatal. Scans of infants who received postnatal steroids and those scans with intracranial pathology were excluded. An increase in the width of the subarachnoid space between initial and subsequent scans was observed. When infants of comparable postconceptional age were compared, subarachnoid space width was greater in the infants with more advanced postnatal age; however, no difference in head circumference was observed. These results suggest that there may be less brain growth during extrauterine existence than would have occurred had the infant remained in utero, and they may help to explain the observation that infants with normal cranial ultrasound studies often have suboptimal neurodevelopmental outcome. Several studies using multivariate analyses to evaluate the relationship between perinatal risk factors in preterm infants and developmental outcome have been reported, and in general, these reports have focused on the ability of abnormal NSG results to predict a poor outcome. Wilson-Costello et al. 28 reported that neurologic impairment was associated independently with chorioamnionitis, septicemia, and severe abnormality on cranial ultrasonography. van de Bor et al. 29 reported a good correlation between ultrasound findings in the neonatal period and neurodevelopmental outcome at 3 years of age. Bennett et al. 30 noted that normal results on cranial sonograms predicted, but did not guarantee, normal outcome. Furthermore, severely abnormal results were predictive of, but did not guarantee, abnormal outcome. These results are similar to those of the present study; however, it should be noted that Bennett et al. 30 included infants with birth weight up to 2430 g, and the inclusion of larger, more mature neonates is a characteristic of many of the studies linking NSG and outcome.
Conversely, Vohr et al. 31 reported BSID II results at 18 to 22 months corrected age for 1151 ELBW neonates. The MDI and PDI scores were more than 2SD below the mean in 37 and 29%, respectively, and they were at least 1SD below the mean in 66 and 59%, respectively. Grades 3-4 IVH and PVL were among the factors significantly associated with increased neurodevelopmental morbidity.
In the present study of only ELBW neonates, we observed a relationship between abnormal NSG-DC and suboptimal outcome. This relationship might be anticipated since the neonates with abnormal NSG-DC required more days on O 2 , were more likely to receive dexamethasone, and had a longer length of stay (Table 1) ; however, a relationship persisted when these variables were controlled in a multinomial logistic regression analysis. Nevertheless, we found that a significant percentage of infants with an abnormal NSG-DC had normal results on MDI (29%) and PDI (33%) at 18 to 22 months corrected age. Furthermore, when the NSG-DC was normal, MDI and PDI scores less than 85 were found in 56 and 43%, respectively, and scores less than 70 were observed in 16 and 8%, respectively. When only those infants in whom all NSG studies during hospitalization were normal were considered, the percentages for BSID II scores less than 85 or less than 70 were remarkably similar to those observed when only the NSG-DC was used (Table 3) . These results indicate that caution should be exercised when suggesting that normal findings, even repeatedly normal findings, can be equated with a favorable outcome in ELBW neonates. In addition, given the apparently greater predictive ability of abnormal NSG with regard to the PDI vs the MDI, it is likely that use of NSG to predict subsequent cognitive ability may be particularly limited in this population. It should be noted that NSG is the least expensive and most readily available form of neuro-imaging available currently.
These results emphasize the complexity of factors that determine neurodevelopmental outcome in ELBW neonates and the importance of variables that might not be expected to influence NSG. The primary role for NSG in ELBW neonates may be in the diagnosis and management of acute problems, such as IVH and posthemorrhagic hydrocephalus, and not as a tool to predict subsequent outcome. These findings indicate that focusing on NSG results may not be advisable when discussing anticipated outcome with parents of ELBW neonates.
